57894-054 : Stelara 130 mg/26ml Intravenous Solution


NDC: 57894-054
Labeler: Janssen Biotech, Inc.
Product Type: Human Prescription Drug
Drug Name:  Stelara
Dosage Form: Intravenous Solution
Application #: BLA761044
Rev. Date: 


NDC Package Codes:

  • 57894-054-16: 1 VIAL, SINGLE‑USE IN 1 BOX (57894‑054‑16) > 26 ML IN 1 VIAL, SINGLE‑USE
  • 57894-054-27: 1 VIAL, SINGLE‑USE IN 1 BOX (57894‑054‑27) > 26 ML IN 1 VIAL, SINGLE‑USE

Active Ingredients:

  • Ustekinumab

Dosage Strength:

  • 130 mg/26mL

Pharmaceutical Classes:

  • Interleukin-12 Antagonists [MoA]
  • Interleukin-23 Antagonist [EPC]
  • Interleukin-23 Antagonists [MoA]
  • Interleukin-12 Antagonist [EPC]

Related Products:

Based on records with the same trade name.
  • 57894-060 Stelara 45 mg/.5ml Subcutaneous Injection, Solution by Janssen Biotech, Inc.
  • 57894-061 Stelara 90 mg/ml Subcutaneous Injection, Solution by Janssen Biotech, Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 57894-054 QR Code

< Prev: 57894-050Next: 57894-060 >

Related Discussions:

Stelara Study
Are you a patient with moderate to severe psoriasis that is currently taking or has taken biologic therapies in the past... 3 replies




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.